Daniel Shepshelovich

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Respiratory Syndrome Coronavirus

Metastatic Colorectal Cancer

Top Venues

Journal of the National Cancer Institute

Cancer medicine

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Zachary W Veitch, Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R Abdul Razak, Anna Spreafico, Philippe L Bedard, Lillian L Siu, Lori M Minasian, Aaron Richard Hansen
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials. Journal of the National Cancer Institute 113 (8) (2022)
Linda Kachuri, Jens Helby, Stig Egil Bojesen, David Chistopher Christiani, Li Su, Xifeng Wu, Adonina Tardón, Guillermo Fernandez-Tardón, John K Field, Michael P A Davies, Chu Chen, Gary E Goodman, Frances A Shepherd, Natasha B Leighl, Ming Sound Tsao, Yonathan Brhane, M Catherine Brown, Kevin Boyd, Daniel Shepshelovich, Lei Sun, Christopher Ian Amos, Geoffrey Liu, Rayjean J Hung
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (7) (2020)
Noam Tau, Dafna Yahav, Daniel Shepshelovich
Vaccine safety - is the SARS-CoV-2 vaccine any different? Human vaccines & immunotherapeutics 17 (5) (2020)
Nathan Kuehne, Lina Chen, Kate McDonald, Lisa Wang, Anna Spreafico, Aaron Hansen, Albiruni Ryan Abdul Razak, Philippe Lucien Bedard, Lillian L Siu, Daniel Shepshelovich
Characterization and outcomes of patients enrolled to multiple phase I cancer trials. Cancer chemotherapy and pharmacology 85 (2) (2019)
Daniel Shepshelovich, Amanda R Townsend, Osvaldo Espin-Garcia, Lidija Latifovic, Chris J O'Callaghan, Derek J Jonker, Dongsheng Tu, Eric Chen, Eric Morgen, Timothy Jay Price, Jeremy Shapiro, Lillian L Siu, Michiaki Kubo, Alexander Dobrovic, Mark J Ratain, Wei Xu, Taisei Mushiroda, Geoffrey Liu
Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. Cancer medicine 7 (11) (2018)